Literature DB >> 6148909

NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease.

J Moss, D L Burns, J A Hsia, E L Hewlett, R L Guerrant, M Vaughan.   

Abstract

In several bacterial diseases, the clinical, laboratory, and histologic findings result from the elaboration by the organism of a toxic product that binds to and may enter the host cell to alter its metabolism. In some cases, the intracellular mediators of toxin action are the cyclic nucleotides, cyclic adenosine 5'-monophosphate (cAMP) and cyclic guanosine 5'-monophosphate (cGMP), the ubiquitous second messengers through which numerous hormones, neurotransmitters, and drugs exert their effects. Certain toxins act by enhancing the activity of cellular enzymes that synthesize cAMP or cGMP; and others, by themselves catalyzing cAMP synthesis after entering the cell. Studies of the mechanism of action of these toxins have helped in deciphering the enzymatic components within animal cells that are responsible for cyclic nucleotide synthesis, degradation, and function as well as in understanding the pathogenesis of the diseases in which they are involved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148909     DOI: 10.7326/0003-4819-101-5-653

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

Review 1.  Bacterial toxins in pediatric infectious diseases.

Authors:  D R Balkundi; A Kumar
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  Pertussis: the disease and the vaccine.

Authors:  R Gold
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

3.  Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.

Authors:  Y Hirabayashi; S I Tamura; K Shimada; T Kurata
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.

Authors:  C W Angus; K P Van Meurs; S C Tsai; R Adamik; M C Miedel; Y C Pan; H F Kung; J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  [Progress in molecular endocrinology].

Authors:  E J Helmreich
Journal:  Klin Wochenschr       Date:  1986-08-01

7.  Expression of the cloned gene for enterotoxin STb of Escherichia coli.

Authors:  R M Lawrence; P T Huang; J Glick; J D Oppenheim; W K Maas
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 8.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors:  H R Masure; R L Shattuck; D R Storm
Journal:  Microbiol Rev       Date:  1987-03

9.  Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells.

Authors:  W F Keane; R Welch; G Gekker; P K Peterson
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

10.  Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.

Authors:  S C Tsai; R Adamik; J Moss; M Vaughan; V Manne; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.